In the last trading session, 10.81 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.10. Most recently the company’s share price was $0.10, and it changed around $0.0 or 0.51% from the last close, which brings the market valuation of the company to $9.50M. CDT currently trades at a discount to its 52-week high of $8.75, offering almost -8650.0% off that amount. The share price’s 52-week low was $0.09, which indicates that the current value has risen by an impressive 10.0% since then. We note from Conduit Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 7.61 million shares, with the 3-month average coming to 13.82 million.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Instantly CDT has showed a green trend with a performance of 0.51% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.1265 on recent trading dayincreased the stock’s daily price by 20.95%. The company’s shares are currently down -97.82% year-to-date, but still down -21.05% over the last five days. On the other hand, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -20.48% down in the 30-day period. We can see from the shorts that 1.07 million shares have been sold at a short interest cover period of 0.11 day(s).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CDT Dividends
Conduit Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in November.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 69.59% of Conduit Pharmaceuticals Inc shares, and 3.18% of them are in the hands of institutional investors. The stock currently has a share float of 10.45%.
